🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

See you in 20 minutes Google DeepMind booth for an intro and update on Isomorphic Labs quest to reimagine drug discovery with AI at #NeurIPS2024

Incredible turnout and energy at our #NeurIPS2024 booth presentation of Isomorphic Labs! Thank you all for the great questions and for cheering us on. There's still time to chat with us about our open roles in ML for drug discovery bit.ly/40Vo4tR

We’re delighted to announce that Sergei Yakneen (Chief Technology Officer, Isomorphic Labs) will be speaking at #FOG2025, sharing insights into how #AI models can advance #drugdiscovery. Register now for your ticket (it’s free for most attendees!): hubs.la/Q030jx0X0

Interested in hearing about the future of #AI in biology and health? We're thrilled to share that Sergei Yakneen (Chief Technology Officer, Isomorphic Labs) will be joining a panel discussion on this topic at #FOG2025! Register now: hubs.la/Q030jHLs0

Scientists clean up nice at the Vienna Science Ball with Michael Bronstein #sciball2025

I'm looking forward to catching up with fellow genomics geeks at #fog2025 this week. Catch my talk on Thursday at 12.20 on the Drug Discovery Stage and panel at 11.20 to get an update on some of the latest work from Isomorphic Labs

Couldn't be more excited to share the news of our expanded collaboration with Novartis! New drug discovery programs, here we come!

Amazing feeling stepping into our brand new office in Lausanne! Come build the future of drug discovery with AI Isomorphic Labs in Switzerland!

A real tour de force technical keynote from Jensen at #GTC25! They are shipping like crazy and being really thoughtful about how to scale for the x100 AI compute we'll need for next generation models. Catch Max Jaderberg and mine talk on our work Isomorphic Labs, Thursday at 10!

Really enjoyed giving this talk at #gtc25 on how Isomorphic Labs is remaining drug discovery with AI. Talk will be available online in a couple of days. So many passionate builders at this conference across all industries, a real inspiration!

Our Chief Technology Officer, Sergei Yakneen, and Chief AI Officer, Max Jaderberg, took the stage at #NVIDIAGTC to discuss how we are applying and developing AI models, including AlphaFold 3 to rationally design therapeutics at Isomorphic Labs. Log in to watch the full session

Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease. We are thrilled to announce $600 million of investment raised in a round led by Thrive Capital with

I'm super excited to share the news of our $600M raise led by Thrive Capital, and with GV and Alphabet! Isomorphic Labs is applying frontier AI to design life-changing medicines with an ambition to solve all disease. All systems go! bit.ly/42cnRlg

Catch me at #GoogleCloudNext next week. I will give a talk on Thu at 10:45AM (lnkd.in/g-Jk6iXW) and a panel at 2:45PM (lnkd.in/gkpfE4a6). Come learn about our AI research, progress on programs, our latest raise, and our mission to solve all disease Isomorphic Labs .

Hanging out at #GoogleCloudNext. Catch my talk Thu. at 10:45AM (lnkd.in/g-Jk6iXW) and a panel at 2:45PM (lnkd.in/gkpfE4a6). Come learn about our AI research, progress on dd programs, our latest $600M raise, and our mission to solve all disease Isomorphic Labs.

“We’re building generalisable AI models capable of learning from the entire universe of protein and chemical interactions. This fundamentally breaks from the target-specific, siloed approach of conventional drug development.” Tune in to hear our Chief Technology Officer,

The ambition at Isomorphic Labs is immense – they’re rethinking drug discovery from the ground up, using AI. 💊 Join Head of Medicinal Drug Design rebecca paul & Chief AI Officer Max Jaderberg as they share the possibilities of AI in tackling disease with host @fryrsquared.

I'm excited to share that Isomorphic Labs is participating in the newly announced OpenBind consortium (gov.uk/government/new…) to generate an unprecedented public dataset of protein-ligand structure and binding data to enable AI research in drug discovery! 500k p-l structures!

Thrilled to share the appointment of Dr. Ben Wolf as our CMO Isomorphic Labs and the opening of our new US office in Kendall Square, Cambridge, MA! Can't wait to partner with Ben on advancing our portfolio towards the clinic and developing the next generation of our tech!

Enjoyed kicking off the OpenBind consortium with members of industry and academia and hosted by UK govt at 10 Downing st. OpenBind will create a huge public data set of protein-ligand structures and binding affinities for AI in drug discovery and Isomorphic Labs is helping drive